• No se han encontrado resultados

CAPÍTULO 3: MODELO DE GESTIÓN DE CALIDAD PARA UNA ASOCIACIÓN DE MYPE DE CURTIEMBRE EN

3.4 P ROPUESTA DE M ODELO DE G ESTIÓN DE C ALIDAD

3.4.4 Procesamiento, Análisis y Mejora

3.4.4.3 Mejora Continua

LEI WANG, MD

overview

■ Definition: heterogeneous left ventricular hypertrophy w/o other cardiac or systemic causes

Septum is usually disproportionately affected.

Left ventricular outflow tract (LVOT) is obstructed during systole by anterior motion of the anterior leaflet of mitral valve against the hypertrophied septum.

The obstruction is dynamic & peaks at mid to late systole.

■ Risk: rare. Inherited as autosomal dominant w/ variable penetrance, or occurs sporadically.

■ About 25% of affected pts present w/ LVOT obstruction.

■ Usual Rx: medical therapy w/ beta blockers, calcium blockers

Less commonly, more invasive therapy such as cardiac myomec-tomy

preop

Issues/Evaluation

■ Most pts are asymptomatic, but symptomatic pts usually complain

of Dyspnea on exertion

Fatigue

Syncope, near syncope

Angina

Sudden death is often the first manifestation in young pts.

■ Key clinical features

Severe diastolic dysfunction

Increased risk for myocardial ischemia

Supraventricular & ventricular arrhythmia common

Pts w/ obstruction present w/ harsh systolic murmur, which is increased w/ Valsalva & decreased w/ squatting or handgrip

EKG shows LVH.

Echocardiography or cardiac catheterization confirms the diagnosis

Hypertrophic Cardiomyopathy 133 What To Do

■ Place pt on beta blocker or calcium channel blocker preop to decrease contractility.

■ Replace preop fluid deficit.

■ Adequate sedation to avoid anxiety-induced sympathetic discharge.

■ Amiodarone is generally effective in controlling arrhythmias.

■ Avoid diuretics, digoxin, or nitrates.

intraop

■ Potential issues

Profound hypotension due to worsening obstruction w/

increases in sympathetic discharge, or decrease in preload or afterload

Myocardial ischemia

Arrhythmia

Management

■ Consider arterial line, CVP, PAC; TEE when large fluid shift is antici-pated.

■ Take efforts to blunt sympathetic stimulation during induction.

Avoid prolonged laryngoscopy.

■ Use volatile anesthetics that decrease ventricular contractility, such as halothane.

■ Avoid tachycardia.

Give beta blocker or calcium channel blocker to treat worsening obstruction.

Avoid agents that can increase heart rate or contractility, such as ephedrine, pancuronium, or epinephrine.

■ Avoid decreases in preload or afterload.

Provide adequate fluid replacement from the very start of proce-dure.

Avoid agents that decrease preload or afterload, such as nitro-glycerin or nitroprusside.

■ Treat hypotension w/ volume expansion & phenylephrine.

postop

■ Aggressive pain control to avoid sympathetic stimulation.

■ Maintain adequate preload & afterload.

■ Continue medical therapy (usually beta blockers, calcium blockers).

134 Hypocalcemia

HYPOCALCEMIA

LUDWIG H. LIN, MD

overview

■ Definition: serum calcium<8 mg/dL, or ionized calcium <1 mmol/L

■ Causes: acute hypocalcemia

Blood transfusions: owing to citrate in banked blood

Critically ill pts: associated w/ sepsis, burns, ARF, pancreatitis

Hypoalbuminemia: reduced total calcium concentration (but normal ionized calcium concentration)

Metabolic alkalosis: increases calcium’s binding to protein, so will decrease ionized calcium concentration

Postop pts following parathyroidectomy or thyroidectomy

■ Causes: chronic hypocalcemia due to parathyroid hormone (PTH) abnormalities

Hypoparathyroidism r Congenital r Hypomagnesemia

r Surgical removal of parathyroids

Ineffective PTH (eg, pseudohypoparathyroidism, vitamin D defi-ciency)

Overwhelmed PTH (eg, hyperphosphatemia from tumor lysis or rhabdomyolysis)

■ Usual Rx

Hypoparathyroidism: vitamin D or calcitriol; calcium supple-ment

Hypomagnesemia: IV magnesium administration

preop

Issues/Evaluation

■ Look for systemic effects of hypocalcemia.

CNS: numbness & circumoral paresthesia, confusion, seizures

Hypotension, increased left ventricular filling pressures

Prolonged QT interval

Weakness & fatigue, skeletal muscle spasm, laryngospasm r Chvostek & Trousseau signs indicate neuromuscular

irritability.

r Chvostek sign: tapping on facial nerve anterior to ear results in ipsilateral facial muscle twitching

Hypocalcemia Hypoparathyroidism 135 r Trousseau sign: inflating BP cuff above systolic pressure for

several minutes results in muscular contraction of the hand

What To Do

■ Confirm hypocalcemia w/ an ionized calcium measurement (to exclude the contribution of the albumin level to the total calcium level).

■ Obtain ECG.

intraop

■ Administer 500 mg to 1 g calcium chloride or calcium gluconate IV, check ionized calcium, & repeat IV calcium administration as needed to correct hypocalcemia.

■ Avoid hyperventilation, as respiratory alkalosis can increase calcium binding to serum proteins.

■ Consider checking phosphate & magnesium levels.

postop

■ Continue to follow serum & ionized calcium levels; continue replace-ment as necessary.

HYPOPARATHYROIDISM

BETTY LEE-HOANG, MD

overview

■ Definition: lack of parathyroid hormone (PTH).

■ Usual Rx: calcium supplement.

■ Hypoparathyroidism usually follows parathyroidectomy or occurs inadvertently after thyroidectomy; idiopathic forms are rare & will not be considered here.

preop

Issues/Evaluation

■ Presents as hypocalcemia: (total serum calcium)<4.5 mEq/L, or ionized calcium<1 mmol/L

■ Chvostek sign is painful facial twitching after tapping on the facial nerve.

■ Trousseau sign is carpal spasm after inflation of a tourniquet.

136 Hypoparathyroidism Hypothyroidism

intraop

■ Treatment is w/ calcium IV in the form of calcium gluconate or cal-cium chloride.

■ Intraop anesthetic agents that depress the myocardium may cause hypotension.

■ Laryngospasm is more likely w/ hypocalcemia.

■ Consider avoiding products that may lower Ca even further if possi-ble, such as citrate-containing blood products & 5% albumin.

postop

■ Continue to follow Ca levels & treat appropriately.

■ After parathyroidectomy, signs of hypocalcemia do not typically appear until after 24–72 h.

HYPOTHYROIDISM

JEREMY NUSSBAUMER, MD BETTY LEE-HOANG, MD

overview

■ Definition: inadequate levels of circulating T3 & T4 hormone

■ Primary hypothyroidism (95% of all cases) may be caused by

Hashimoto’s thyroiditis (autoimmune)

Thyroidectomy

Radioactive iodine treatment

Iodine deficiency

Antithyroid medication

Neck irradiation

■ Diagnosis of primary hypothyroidism: low levels of free thyroxine &

increased TSH

■ Secondary hypothyroidism is caused by failure of the hypothalamic-pituitary axis.

■ Signs/symptoms of hypothyroidism may include

Fatigue, weakness

Weight gain despite poor appetite

Cold intolerance